JAY ITALIYA: Open Payments
NPI 1194221606 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 22 payments from 7 companies in 2025. Trend: 2023 $137 · 2024 $180 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $154 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| HARMONY BIOSCIENCES LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: VRAYLAR, Auvelity, SPRAVATO, HORIZANT, WAKIX, REXULTI, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
